|
|
|
|
|
GS Electromedical (Kaufering, Germany) and Masimo
Corporation (Irvine, CA) today announced an agreement under which GS
Electromedical will integrate Masimo’s pulse oximetry signal processing and
sensor technologies into its current and future defibrillators/monitors that include pulse oximetry. Masimo, a privately-held developer of proprietary signal
processing and sensor technologies, has created a novel approach that measures
arterial oxygen saturation and pulse rate even in the presence of motion
artifact.
Gunter Stemple, President of GS Electromedical, stated, "Our
primary products are defibrillators and monitors used in emergency medical
applications. In these applications, the current pulse oximetry technology has
proven to be largely ineffective due to problems caused by patient motion, low
perfusion and ambient light. We believe that Masimo has effectively solved these
problems and has thus created a new standard of performance for this vital
measurement. We are happy to be one of the first companies in our market to be
able to offer our customers this quantum leap in performance and
reliability."
Joe E. Kiani, President and Chief Executive Officer of
Masimo Corporation, stated, "Conventional pulse oximetry brings little or no
value in the emergency medical application due to its inability to give reliable
arterial blood oxygen saturation and pulse rate measurement under these
challenging conditions. We are delighted that the people at GS Electromedical
have recognized the shortcomings of conventional pulse oximeters and have
embraced Masimo SET pulse oximetry for the benefit of patient
care."
Masimo designs, develops and licenses advanced medical signal
processing and sensor technology for the noninvasive monitoring of vital
physiological parameters. Masimo is located in Irvine, California.
GS
Electromedical designs, manufactures and distributes defibrillators and other
equipment used primarily in emergency medical applications. GS Electromedical is
located in Kaufering, Germany and primarily serves the European market. |
|
|
|
|
|
|
